Active Litigation, Accepting Clients

Families of premature infants diagnosed with NEC after cow's milk-based formula may qualify for a free case review.

DefendantAbbott Laboratories (Similac) and Mead Johnson / Reckitt (Enfamil)
MDLMDL 3026
CourtN.D. Ill., Chief Judge Rebecca R. Pallmeyer
Filing DeadlineVaries by state; special rules often apply to claims involving minors. Prompt review is important.

Get a Free Case Review

NEC Baby Formula Lawsuit

Necrotizing enterocolitis (NEC) is a devastating intestinal disease that primarily strikes premature and low-birth-weight infants, causing intestinal tissue to become inflamed and die. It can require emergency surgery to remove sections of the bowel and is fatal in a significant share of severe cases. Survivors may face lifelong complications including short bowel syndrome and developmental delays.

Why Are NEC Baby Formula Lawsuits Being Filed?

Families allege that cow’s milk-based formulas and fortifiers made for premature infants — Abbott’s Similac products and Mead Johnson’s Enfamil products — significantly increase the risk of NEC compared to human milk, and that the manufacturers failed to warn parents and NICU providers. Decades of medical research, including a 2024 Cochrane review, has reported that human milk feeding is associated with roughly half the NEC risk of formula feeding in preterm infants. The manufacturers deny the allegations and maintain their products are safe and essential nutrition for premature babies.

Verdicts and Where the Litigation Stands

Federal cases are consolidated in MDL 3026 in the U.S. District Court for the Northern District of Illinois before Chief Judge Rebecca R. Pallmeyer, with roughly 800 cases pending as of mid-2026. The litigation has produced a split record. In state courts, juries returned a $60 million verdict against Mead Johnson in Illinois in 2024 (later ordered to a new trial), a $495 million verdict against Abbott in Missouri in 2024, and another multimillion-dollar verdict for four families in Chicago in April 2026. In the federal MDL, the first three bellwether cases were dismissed on summary judgment, but a court ruling preserved plaintiffs’ key epidemiology expert heading into the next bellwether trial, set for mid-2026. No global settlement has been announced.

Who May Qualify?

You may qualify for a free case review if your child was born prematurely, was fed a cow’s milk-based formula or fortifier (such as Similac or Enfamil preterm products) in the hospital or NICU, and was then diagnosed with necrotizing enterocolitis. Cases involving surgery, long-term injury, or the loss of a child are the focus of the litigation. NICU feeding records and the NEC diagnosis are the core evidence — and hospitals document NICU feeding carefully, so this evidence usually exists even if you never saw it.

Nothing about these lawsuits second-guesses parents. Families were not told of any risk, and feeding decisions in the NICU are typically made by the care team. These claims are about what the manufacturers allegedly knew and did not say.

Injuries Linked to This Litigation

  • Necrotizing enterocolitis (NEC) in premature infants
  • NEC requiring surgery
  • Wrongful death of an infant

Do You Qualify?

Child was born prematurely
Fed a cow’s milk-based formula or fortifier (Similac or Enfamil preterm products) in the hospital or NICU
Diagnosed with necrotizing enterocolitis (NEC), particularly cases involving surgery, long-term injury, or death

Get a Free Case Review

Name(Required)
Which product were you exposed to, and what injury or diagnosis followed?
Consent(Required)

Attorney Advertising. Prior results do not guarantee a similar outcome. Submitting a form does not create an attorney client relationship.